SARS CoV-2 (COVID-19) Current Pharmacotherapy for Mother and Infant
The novel coronavirus disease 2019 (COVID-19), appeared in the United States over 1 year ago. This virus has a wide range of presentations, from being asymptomatic to causing severe acute respiratory syndrome, which can lead to death. It has led to a worldwide effort to find effective treatments, from repurposed medications to new discoveries, as well as the push to develop effective vaccines. As the race to fight this pandemic unfolds, this column provides what is currently available to combat this virus, how it has been utilized in the pregnant population, and what data have been made available about how these treatments affect fetal development and the neonate.
Thigpen, Jim. 2021. SARS CoV-2 (COVID-19) Current Pharmacotherapy for Mother and Infant. Neonatal Network. Vol.40(3). 175-182. https://doi.org/10.1891/11-T-737 PMID: 34088863 ISSN: 0730-0832